Insys Therapeutics (INSY) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. CDNS
3. SPY
4. META
5. JBLU
6. ANT
7. ARTV
8. AAPL
9. SSD
10. BA

Go back to Insys Therapeutics (INSY) Misses Q2 EPS by 1c

Insys Therapeutics Reports Second Quarter 2016 Results

August 3, 2016 6:50 AM EDT

PHOENIX, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced financial results for the three-month period ended June 30, 2016.

Highlights of and subsequent to the second quarter of 2016 include:

Total net revenue was $67.1 million, compared to $77.6 million for the second quarter of 2015;Net income totaled $4.4 million, or $0.06 per basic and $0.06 per diluted share, compared to net income of $7.3 million, or $0.10 per basic and $0.10 per diluted share, for the second quarter of 2015;Cash, cash equivalents and investments were $193.7 million as of June 30, 2016;... More